EntryPoint Capital LLC boosted its stake in shares of agilon health, inc. (NYSE:AGL - Free Report) by 275.8% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 233,069 shares of the company's stock after acquiring an additional 171,052 shares during the period. EntryPoint Capital LLC owned 0.06% of agilon health worth $443,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently bought and sold shares of AGL. Vanguard Group Inc. increased its holdings in shares of agilon health by 0.9% in the fourth quarter. Vanguard Group Inc. now owns 31,112,407 shares of the company's stock worth $59,114,000 after purchasing an additional 272,787 shares during the last quarter. State Street Corp increased its stake in agilon health by 3.0% in the 3rd quarter. State Street Corp now owns 7,449,706 shares of the company's stock worth $29,277,000 after acquiring an additional 215,733 shares during the last quarter. Geode Capital Management LLC raised its holdings in shares of agilon health by 1.2% during the 3rd quarter. Geode Capital Management LLC now owns 6,893,517 shares of the company's stock worth $27,097,000 after acquiring an additional 84,889 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its position in shares of agilon health by 49.2% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 4,541,549 shares of the company's stock valued at $8,629,000 after acquiring an additional 1,498,524 shares during the last quarter. Finally, Citigroup Inc. grew its holdings in shares of agilon health by 2,251.5% in the third quarter. Citigroup Inc. now owns 2,028,246 shares of the company's stock valued at $7,971,000 after purchasing an additional 1,941,993 shares in the last quarter.
agilon health Price Performance
Shares of agilon health stock traded down $0.13 on Friday, hitting $4.48. The company's stock had a trading volume of 3,482,811 shares, compared to its average volume of 4,640,700. The company has a market capitalization of $1.85 billion, a price-to-earnings ratio of -4.77 and a beta of 0.67. The firm has a fifty day moving average price of $3.67 and a 200-day moving average price of $2.98. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. agilon health, inc. has a 1 year low of $1.50 and a 1 year high of $7.73.
Wall Street Analyst Weigh In
Several equities analysts have commented on the stock. Stifel Nicolaus increased their price objective on shares of agilon health from $2.00 to $3.00 and gave the company a "hold" rating in a research report on Wednesday, February 26th. Macquarie started coverage on agilon health in a research report on Monday, December 16th. They issued a "neutral" rating and a $3.00 price target for the company. Sanford C. Bernstein upped their price objective on agilon health from $2.50 to $3.15 and gave the company a "market perform" rating in a research report on Wednesday, January 15th. Citigroup raised agilon health from a "sell" rating to a "neutral" rating and boosted their target price for the company from $1.75 to $2.25 in a research report on Friday, January 10th. Finally, Needham & Company LLC reaffirmed a "hold" rating on shares of agilon health in a research note on Friday, March 21st. Two investment analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus price target of $3.95.
Check Out Our Latest Report on AGL
agilon health Company Profile
(
Free Report)
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Featured Articles
Before you consider agilon health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and agilon health wasn't on the list.
While agilon health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
